Researchers from the University of Minnesota have published a study in Nature Communications introducing a new biocomputing method, Transcriptional RNA Universal Multi-Purpose GatE PlaTform (Trumpet), which leverages biological enzymes as …
In a recent announcement, Moderna and IBM unveiled their partnership aimed at utilizing cutting-edge technologies, such as artificial intelligence (AI) and quantum computing, to accelerate research in messenger RNA (mRNA) …
STB CLOUD is Syntekabio’s latest cloud-based, fully automated AI platform. It’s designed for developers to engage in their drug discovery and development processes to find drug candidates easier and faster.
The terms “big data”, “machine learning”, and “artificial intelligence” have been trending in the AI drug discovery space for several years, both in mainstream media and academic press. These new …
Established in 2017 in Swiss, RetinAI Medical AG is a notable player in clinical and imaging data management software and advanced analytics using artificial intelligence (AI) for ophthalmology, which has …
Myricx Pharma, an oncology drug discovery company specializing in precision medicines based on its N-myristoyltransferase (NMT) platform, has recently presented positive pre-clinical proof of concept data at the American Association …
In a world where innovation and collaboration play a critical role in the development of cutting-edge therapies, Enamine Ltd. and Endogena Therapeutics AG have forged a strong partnership to drive …
Macomics Ltd, a frontrunner in macrophage drug discovery, recently showcased its innovative ENIGMAC™ macrophage drug discovery platform at the American Association for Cancer Research's Annual Meeting (AACR 2023). The company …
Cerner Enviza, an Oracle company, and John Snow Labs have been selected by the FDA's Sentinel Innovation Center to support the Sentinel Initiative, focusing on AI drug discovery and real-world …
PsychoGenics, a prominent player in AI-enabled phenotypic drug discovery and preclinical CRO services, has recently unveiled eCube, an innovative pharmaco-electroencephalography (pharmacoEEG) platform designed to enhance phenotypic drug discovery. By employing …
Americans are increasingly concerned about rising drug prices. FDA user fees affect drug pricing competition, which is often overlooked. FDA user fees fund regulatory activities and encourage timely reviews and …
ConcertAI, an AI Software-as-a-Service (SaaS) and Real-World Evidence (RWE) solutions provider for the life sciences and healthcare sectors, recently announced the launch of its Clinical Trial Optimization (CTO 2.0) platform. The …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.